Morning Briefing
Summaries of health policy coverage from major news organizations
Pfizer, GlaxoSmithKline To Increase Sales Of Pneumococcal Vaccines Through GAVI
Pharmaceutical companies Pfizer and GlaxoSmithKline are increasing their sales of reduced-cost pneumonia vaccines to developing countries through the GAVI Alliance "by more than 50 percent, marking the scale-up of an international program to protect millions of children," Reuters reports (Hirschler, 12/16).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
